Lecture Series Archive

Clinical Approaches and Scientific Advances in Ophthalmology Minisymposium Lecture Series Previous Events:

Molecular Mechanisms of AMD – Oxidative Stress and Retinotoxicity:December 13th, 2013

  • Clinical Component:James T. Handa, MD, Johns Hopkins University
  • Basic Science Component:Krystof Palczewski, PhD, Case Western Reserve University

Biomarkers in Retinal Disease: October 25th, 2013

  • Clinical Component: Timothy W. Olsen, MD, Emory University
  • Basic Science Component: Demetrios Vavvas, MD PhD, Harvard University

Translational Frontiers in Hereditary Retinal Degeneration: April 30th, 2013

  • Clinical Component: Daniel Chung, DO, University of Pennsylvania
  • Research Component: José-Alain Sahel MD, PhD, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France

Vascular Insufficiency or Neurodegeneration: Primary Factors in Glaucoma Progression: April 12th, 2013

  • Clinical Component: Paul A. Kaufman, MD, University of Wisconsin
  • Research Component: Claude F. Burgoyne, MD, Devers Eye Institute

Pathogenesis, Classification, and Treatment of Intraocular Tumors: March 22nd, 2013

  • Clinical Component: Jerry Shields, MD, Wills Eye Institute, Philadelphia, PA
  • Basic Science Component: Michael Dyer, PhD, St. Jude’s Children’s Research Hospital, Memphis, TN

Translational Frontiers in Hereditary Retinal Degenerations: April 30th, 2013

  • Jean Bennett, MD, PhD, University of Pennsylvania
  • José-Alain Sahel MD, PhD, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France

Vascular Insufficiency or Neurodegeneration: Primary Factors in Glaucoma Progression: April 12th, 2013

  • Clinical Component: Paul Kaufman, MD, University of Wisconsin
  • Basic Science Component: Claude Burgoyne, MD, Devers Eye Institute

Pathogenesis, Classification, and Treatment of Pediatric Intraocular Tumors: March 22nd, 2013

  • Clinical Component: Jerry Shields, MD, Wills Eye Institute, Philadelphia, PA
  • Basic Science Component: Michael Dyer, PhD, St. Jude's Children's Research Hospital, Memphis, TN

The Future of Targeted Therapeutics for Diabetic Retinopathy: November 16th, 2012

  • Clinical Component: Thomas Gardner, MD, University of Michigan
  • Basic Science Component: Sayon Roy, PhD, Boston University

Ocular Pharmacokinetics and Drug Delivery Strategies: October 26th, 2012

  • Clinical Component: Barry Kuppermann, MD, PhD, UC Irvine
  • Basic Science Component: Uday Kompella, PhD, U Colorado-Denver

Therapeutic Responses and Advanced Imaging in AMD: April 20th, 2012Sadda and Martin visit

  • Daniel F. Martin, M.D., Cole Eye Institute, Cleveland Clinic, Cleveland, OH
  • SriniVas Sadda, M.D., Doheny Eye Institute, USC, Los Angeles, CA

Inflammation and Neuroprotection in Retinal Disease: February 24th, 2012

  • Paul A. Sieving, M.D., Ph.D., Director of the National Eye Institute, Bethesda, MD
  • John P. Atkinson, M.D., Washington University, St. Louis, MO

Disease Mechanisms and Targeted Therapeutics in Retinal Vascular Disease: December 2nd, 2011

  • Patricia A. D'Amore, Ph.D., Harvard University, Boston, MA
  • Michael T. Trese, M.D., William Beaumont Hospital, Royal Oak, MI

Vascular Disease in the Developing Retina: November 4th, 2011Lutty & Hartnett visit

  • Gerard Lutty, Ph.D., Johns Hopkins University, Baltimore, MD
  • Mary. E. Hartnett, M.D., Ph.D. University of Utah, Salt Lake City, UT

Forum on Global Ophthalmology Initiatives: October 28th, 2011Rao Visit

  • Gullapalli N. Rao, M.D., Chair and Founder of L.V. Prasad Eye Institute, Hyderabad, India

The Aging Macula: April 29th, 2011

Uveal Melanoma: Pathogenetic Mechanisms and Clinical Approaches: February 4th, 2011

Diagnostic and Therapeutic Challenges in Uveitis: January 7th, 2011

Clinical Variations and Therapeutic Options in Glaucoma: December 3rd, 2010

Advances in Surgical Diseases of the Anterior Segment: November 12th, 2010

Etiologies and Targeted Therapies for Glaucomatous Optic Neuropathy: June 11th, 2010

  • Basic Science Component: Jeffrey L. Goldberg, MD, PhD, Bascom Palmer
  • Clinical Component: Pratap Challa MD, Duke University

Mechanisms of Corneal Neovascularization and Transplant Rejection: May 28th, 2010

  • Basic Science Component: Balamurali Ambati, MD, PhD, University of Utah
  • Clinical Component: Jay Krachmer, MD, University of Minnesota

Diagnostic and Therapeutic Challenges in Uveitis: March 19th, 2010

  • Basic Science Component: James T. Rosenbaum, MD, Oregon Health
    and Science University
  • Clinical Component: Sunil Srivastava, MD, Emory University